| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/06/2003 | WO2002070651A3 Viral reporter particles |
| 03/06/2003 | WO2002062959A3 Hepatitis b virus treatment |
| 03/06/2003 | WO2002060929A3 Polymer conjugates of neublastin and methods of using same |
| 03/06/2003 | WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor |
| 03/06/2003 | WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof |
| 03/06/2003 | WO2002015701A3 Bacillus thuringiensis crystal protein hybrids |
| 03/06/2003 | WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 03/06/2003 | WO2001098343A9 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 03/06/2003 | WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 03/06/2003 | US20030044901 Polypeptide for use in animal models associated with human therapeutics |
| 03/06/2003 | US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 03/06/2003 | US20030044423 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype |
| 03/06/2003 | US20030044405 Sustained release; drug delivery; tissue adhesive |
| 03/06/2003 | CA2458866A1 Compositions and methods of treating diabetes |
| 03/06/2003 | CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 03/06/2003 | CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 03/06/2003 | CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 03/05/2003 | EP1287149A2 High level production of p-hydroxybenzoic acid in green plants |
| 03/05/2003 | EP1287147A2 Immunotoxin fusion proteins and means for expression thereof |
| 03/05/2003 | EP1287138A1 Novel g-protein coupled receptor |
| 03/05/2003 | EP1287131A2 Regulator of g protein signalling (rgs8) |
| 03/05/2003 | EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 03/05/2003 | EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/05/2003 | EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/05/2003 | EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/05/2003 | EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 03/05/2003 | EP0656952B1 Cationic peptides and method for production |
| 03/05/2003 | EP0625157B1 PLATELET GPIIIa P1A1 AND P1A2 EPITOPES, THEIR PREPARATION AND USE |
| 03/05/2003 | EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors |
| 03/04/2003 | WO2002020614A2 Endoglin-specific polypeptide, production and use thereof |
| 03/04/2003 | US6528699 Inserting nucleic acid construct which comprises promoter, milk protein specific signal sequence; can use for treating diabetes and multiple sclerosis |
| 03/04/2003 | US6528623 Antibodies that specifically bind ACT-4-L-h-1 ligand |
| 03/04/2003 | US6528276 Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity |
| 03/04/2003 | US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases |
| 03/04/2003 | US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast |
| 03/04/2003 | CA2421202A1 Endoglin-specific polypeptide, production and use thereof |
| 03/04/2003 | CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 02/27/2003 | WO2003016535A2 Novel amylases and uses thereof |
| 02/27/2003 | WO2003016517A2 Kinase crystal structures |
| 02/27/2003 | WO2003016506A2 Secreted proteins |
| 02/27/2003 | WO2003016472A2 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/27/2003 | WO2003016349A1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue |
| 02/27/2003 | WO2003016342A2 Tumor antigens for prevention and/or treatment of cancer |
| 02/27/2003 | WO2003016333A2 Virus coat protein/receptor chimeras and methods of use |
| 02/27/2003 | WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 02/27/2003 | WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine |
| 02/27/2003 | WO2003015697A2 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002055725A3 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 02/27/2003 | WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002031156A3 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/27/2003 | WO2002020768A3 Caveolin peptides and their use as therapeutics |
| 02/27/2003 | WO2002016548A8 Novel g protein-coupled receptor |
| 02/27/2003 | WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/27/2003 | WO2002008267A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | US20030040038 Screening effect of modulators on target cells; obtain cell, transform with expresion vector coding activator and preferential protein, monitor cell activity, compare to control |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039660 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 02/27/2003 | US20030039655 Novel engineered superantigen for human therapy |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2457850A1 Novel amylases and uses thereof |
| 02/27/2003 | CA2457461A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 02/27/2003 | CA2456470A1 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | CA2454860A1 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/26/2003 | EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions |
| 02/26/2003 | EP1285272A2 Compositions and methods for screening therapeutic agents |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285066A1 F-box containing protein |
| 02/26/2003 | EP1285065A2 Long wavelength engineered fluorescent proteins |
| 02/26/2003 | EP1285054A1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 02/26/2003 | EP1285004A1 Synthetic peptides and uses therefore |
| 02/26/2003 | EP1284998A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 02/26/2003 | EP1284997A2 Therapeutic compounds for ovarian cancer |
| 02/26/2003 | EP1284993A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 02/26/2003 | EP1284986A1 Javelinization of protein antigens to heat shock proteins |
| 02/26/2003 | EP0728191B1 A secretion sequence for the production of a heterologous protein in yeast |
| 02/26/2003 | CN1399646A Recombinant fusion molecules |
| 02/26/2003 | CN1399645A Human monolonal antibodies to HER2/NEU |
| 02/26/2003 | CN1399556A APRIL receptor (BCMA) and uses thereof |
| 02/25/2003 | US6525187 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/25/2003 | US6525180 Antibodies to mammalian T cell surface antigen |
| 02/25/2003 | US6524850 Glutathione-S- transferase (GST):Wee1 fusion protein |
| 02/25/2003 | US6524825 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
| 02/20/2003 | WO2003014721A2 Chimeric protein and its use in electron transfer methods |
| 02/20/2003 | WO2003014381A1 System for detecting protease |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014159A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2002098360A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |